References
- Baerts W, Fetter W P, Hop W C, Wallenburg H C, Spritzer R, Sauer P J. Cerebral lesions in preterm infants after tocolytic indomethacin. Dev Med Child Neurol 1990; 32: 1032
- Norton M E, Merrill J, Cooper B A, Kuller J A, Clyman R I. Neonatal complications after the administration of indomethacin for pretem labor. N Engl J Med 1993; 25: 1602–1607
- Iannucci T A, Besinger R E, Fisher S G, Gianopoulos J G, Tomich P G. Effect of dual tocolysis on the incidence of severe intraventricular hemorrhage among extremely low-birth-weight infants. Am J Obstet Gynecol 1996; 175: 1043–1046
- Suarez R D, Grobman W A, Parilla B V. Indomethacin tocolysis and intraventricular hemorrhage. Obstet Gynecol 2001; 97: 921–925
- Weintraub Z, Solovechick M, Reichman B, Rotshcild A, Waisman D, Davkin O, Lusky A, Bental Y. Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular hemorrhage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2001; 85: F13–F17, in collaboration with Israel Neonatal Network
- Allan W C, Vohr B, Makuch R W, Katz K H, Ment L R. Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage. Arch Pediatr Adolesc Med 1997; 151: 580–585
- Saliba E, Autret E, Nasr C, Suc A L, Laugier J. Perinatal pharmacology and cerebral blood flow. Biol Neonate 1992; 62: 252–257
- Leffler C W, Busija D W, Fletcher A M, Beasley D G, Hessler J R, Green R. Effects of indomethacin upon cerebral hemodynamics of newborn pigs. Pediatr Res 1985; 19: 1160–1164
- Spinillo A, Chiara A, Bergante C, Biancheri D, Fabiana D, Fazzi E. Obstetric risk factors and persistent increases in brain parenchymal echogenicity in preterm infants. Br J Obstet Gynaecol 2004; 111((9))913–918
- Major C, Lewis D, Harding J, Porto M, Garite T. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low birth weight neonate. Am J Obstet Gynecol 1994; 170: 102–106
- Souter D, Harding J, McCowan L, O'Donnell C, McLeay E, Baxendale H. Antenatal indomethacin – adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol 1998; 38: 11–16
- Gardner M O, Owen J, Skelly S, Hauth J C. Preterm delivery after indomethacin. A risk factor for neonatal complications?. J Reprod Med 1996; 41: 903–906
- Vermillion S T, Scardo J A, Lashus A G, Wiles H B. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 1997; 177: 256–259
- Macones G A, Marder S J, Clothier B, Stamilio D M. The controversy surrounding indomethacin for tocolysis. Am J Obstet Gynecol 2001; 184: 264–272
- Pinto-Martin J A, Whitaker A H, Feldman J F, Van Rossem R, Paneth N. Relation of cranial ultrasound abnormalities in low birthweight infants to motor and cognitive performance at 2, 6 and 9 years. Dev Med Child Neurol 1999; 41: 826–833
- Volpe J J. Cerebral White Matter Injury of the premature infant – more common than you think. Pediatrics 2003; 112: 176–180
- Volpe J J. Brain injury in the premature infant: Current concepts. Biol Neonate 1996; 69: 167–169
- Back S A, Han B H, Luo N L, Chricton C A, Xanthoudakis S, Tam J, Arvin K L, Hotlzman D M. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002; 22: 455–463
- Hagberg H, Peebles D, Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic and excitotoxic insults. Ment Retard Dev Disabil Res Rev 2002; 8: 30–38
- Counsell S J, Allsop J M, Harrison M C, Larkman D J, Kennea N L, Kapellou O, Cowan F M, Hajnal J V, Edwards A D, Rutherford M A. Diffusion-weighted imaging of the brain in preterm infants with focal and diffuse white matter abnormality. Pediatrics 2003; 112: 1–7